Prospective observational study on relationship between plasma-free amino acids profiles and risk of mild cognitive impairment, including future risk of Alzheimer's disease onset
Not Applicable
- Conditions
- Mild Cognitive Impairment (MCI), Alzheimer's disease (AD)
- Registration Number
- JPRN-UMIN000021965
- Lead Sponsor
- iigata University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up continuing
- Sex
- All
- Target Recruitment
- 600
Inclusion Criteria
Not provided
Exclusion Criteria
Subjects who have taken any amino acid-formulations, supplements, and bevarage within 10 hours before the blood collection. Subjects who have taken meals within 10 hours before the blood collection. Subjects who have been educated for less than 6 years. Subjects who have previous history or are under medical treatment for alcohol addiction. Patients of cancer or cirrhosis of liver. Dialysis patients Subjects who developed other neurodegenerative or mental disorders. In addition to above, subjects who are judged as ineligible by the medical doctors who are responsible for this trial as investigators.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method